A patient receiving immunotherapy with a PD-1 inhibitor develops a new rash and diarrhea. What should the nurse suspect first?
-
A
Disease progression requiring new chemotherapy
-
B
Immune-related adverse events (irAEs) requiring immune-modulating treatment
-
C
Infectious colitis requiring broad-spectrum antibiotics
-
D
Drug-drug interaction from a new supplement